Aardvark Therapeutics, Inc. (AARD)
13.12
-0.10
(-0.76%)
USD |
NASDAQ |
Dec 31, 16:00
13.10
-0.02
(-0.15%)
After-Hours: 20:00
Aardvark Therapeutics EPS Diluted (Quarterly): -0.7503 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Insmed, Inc. | -1.747 |
| Immunic, Inc. | -0.1319 |
| Soleno Therapeutics, Inc. | 0.4736 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.32M |
| Total Expenses (Quarterly) | 16.32M |
| Enterprise Value | 159.97M |
| Earnings Yield | -17.12% |
| Normalized Earnings Yield | -17.11 |